Several drugs indicated for cancer treatment presented negative correlations with AD profiles, including the aromatase inhibitor exemestane used for the treatment of BRCA, the progestin medication megestrol, the alkylating agent thiotepa, tretinoin, and estradiol [44]. This evidence concerns the gene CYP19A1 and Alzheimer disease.